Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3 Meeting Abstract
| Authors: | Oluwole, O. O.; Ghobadi, A.; Cassaday, R. D.; Park, J. H.; Houot, R.; Logan, A.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; O'Dwyer, K. M.; Baer, M. R.; Schiller, G. J.; Abedi, M.; Minnema, M. C.; Stiff, P. J.; Zhou, L.; Siddiqi, R.; Khalid, R. D.; Shah, B. D. |
| Abstract Title: | Long-term survival outcomes of patients (pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3 |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401600 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.6531 |
| Notes: | Meeting Abstract: 6531 -- Source: Wos |
